Champions Oncolog (CSBR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
| 07-2023 | 04-2023 | 01-2023 | 10-2022 | 07-2022 | |
| Sales | 12,561 | 13,071 | 12,773 | 14,281 | 13,745 |
| Cost of Goods | 7,684 | 7,338 | 7,699 | 7,443 | 7,052 |
| Gross Profit | 4,877 | 5,733 | 5,074 | 6,838 | 6,693 |
| Operating Expenses | 8,113 | 8,592 | 8,231 | 7,274 | 7,029 |
| Operating Income | -2,552 | -2,521 | -2,458 | 7 | -284 |
| Other Income | 14 | -20 | 36 | -9 | -18 |
| Pre-tax Income | -2,538 | -2,541 | -2,422 | -2 | -302 |
| Income Tax | 28 | 20 | 17 | 14 | 17 |
| Net Income Continuous | -2,566 | -2,561 | -2,439 | -16 | -319 |
| Net Income | $-2,566 | $-2,561 | $-2,439 | $-16 | $-319 |
| EPS Basic Total Ops | -0.19 | -0.19 | -0.18 | 0.00 | -0.02 |
| EPS Basic Continuous Ops | -0.19 | -0.19 | -0.18 | 0.00 | -0.02 |
| EPS Diluted Total Ops | -0.19 | -0.19 | -0.18 | 0.00 | -0.02 |
| EPS Diluted Continuous Ops | -0.19 | -0.19 | -0.18 | 0.00 | -0.02 |
| EBITDA(a) | $-2,107 | $-1,938 | $-1,883 | $567 | $244 |